The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 122-140

  Hausdorff, William P ^b   Bryant, John ^a   Kloek, Carolyn ^a   Paradiso, Peter R ^c   Siber, George R ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b PFIZER INC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BLOOD; CEREBROSPINAL FLUID; DATA BASE; MIDDLE EAR; OTITIS MEDIA; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINE PRODUCTION;

ADOLESCENT; ADULT; BACTEREMIA; BACTERIAL VACCINES; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; OTITIS MEDIA WITH EFFUSION; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 0033969244     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313609     Document Type: Article

References (61)

1. Advisory Committee on Immunization Practices. Prevention of pneumococcal disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46.
2. Global Programme for Vaccines and Immunization: report of the Meeting of Scientific Group of Experts (SAGE) of the Children's Vaccine Initiative and the Global Programme for Vaccines and Immunization. Geneva: World Health Organization, 1996.
3. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 1993; 12:389-94.
4. Goetghebuer T, West T, Wermenbol V, et al. Outcome of pneumococcal and Haemophilus influenzae type b meningitis in Gambian children. Trop Med Int Health 1999.
5. Fedson DS, Musher DM, Eskola J. Pneumococcal vaccine. In: Plotkin SA, Orenstein WA, ed. Vaccines. 3d ed. Philadelphia: WB Saunders, 1998: 553-607.
6. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. part I. Clin Infect Dis 2000; 30:100-21.
7. Children's Vaccine Initiative. A pneumococcal vaccine to save children of all ages nears final testing. CVI Forum 1996; 13:3-11.
8. Scott JAG, Hall AJ, Dagan R, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex and geography in 7000 episodes of invasive disease. Clin Infect Dis 1996;22:973-81.
9. Sniadack DH, Schwanz B. Lipman H, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children - implications for vaccine strategies. Pediatr Infect Dis J 1995; 14:503-10.
10. Austrian R. The enduring pneumococcus: unfinished business and opportunities for the future. Microb Drug Resist 1997; 3:111-5.
11. Orange M, Gray BM. Pneumococcal serotypes causing disease in children in Alabama. Pediatr Infect Dis J 1993; 12:244-5.
12. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995; 171:885-9.
13. Hibbs JR, John MD Jr, Judson FN, McGill WL, Rietmeijer CAM, Janoff EN. Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994. Clin Infect Dis 1997;25:195-9.
14. Jette LP, Lamothe F. Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol 1989;27:1-5.
15. Saha SK, Rikitomi N, Biswas D, et al. Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995. J Clin Microbiol 1997; 35:785-7.
16. Shen SJ, The Cooperation Group on Pneumococcal Serotyping. Serotypes and epidemiological study of pneumococcal infection in 18 provinces (cities) in China. Chung Hua Liu Hsing Ping Hsueh Tsa Chill 1989; 10:133-7.
17. Lakshmy A, Malhotra VL. Serotype distribution of clinical isolates of Streptococcus pneumoniae from a Delhi hospital. Adv Exp Med Biol 1997;418:273-4.
18. Mastro TD, Ghaffor A, Nomani NK, et al. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 1991; 337:156-9.
19. Rahav G, Toledano Y, Engelhard D, et al. Invasive pneumococcal infections: a comparison between adults and children. Medicine 1997; 76:295-303.
20. Dagan R, Englehard D, Piccard E. Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA 1992;268:3328-32.
21. Crewe-Brown HH, Karstaedt AS, Saunders GI, et al. Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis 1997; 25:1165-72.
22. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992;268:3323-7.
23. Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM). Bacterial meningitis in the Netherlands: annual report, 1996. Amsterdam: University of Amsterdam, 1997.
24. Reinert RR, Kaufhold A, Schlaeger JJ, Mechery V, Lutticken R. Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996. Pediatr Infect Dis J 1997; 16:244-5.
25. Fenoll A, Jado I, Viciso D, Perez A, Casal J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol 1998; 36:3447-54.
26. Geslin P, Fremaux A, Sissia G, Spicq C, Aberrane S. Rapport d'activite annee 1996. Paris: Centre National de Reference des Pneumocoques, 1996.
27. Castaneda E, Leal AL, Castillo O, et al. Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Columbian children. Microb Drug Resist 1997;3:147-52.
28. Voss L, Lennon D, Okesene-Gafa K, Ameratunga S, Martin D. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand. Pediatr Infect Dis J 1994; 13:873-7.
29. Martin DR, Brett MS. Pneumococci causing invasive disease in New Zealand, 94: serogroup and serotype coverage and antibiotic resistance. N Z Med J 1996; 109:288-90.
30. Plouffe JF, Moore SK, Davis R, Facklam RR. Serotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio. J Clin Microbiol 1994;32:1606-7.
31. Raz R, Elhanan G, Shimoni Z, et al. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Clin Infect Dis 1997;24:1164-8.
32. Paul J, Bates J, Kimari J, Gilks C. Serotypes and antibiotic susceptibilities of Streptococcus pneumoniae in Nairobi, Kenya. J Infect 1996; 32:139-42.
33. Linares J, Pallares R, Alonso T, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Belivitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15:99-105.
34. Wust J, Huf E, Kayser FH. Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland. J Clin Microbiol 1995;33:3159-63.
35. Kragsbjerg P, Kallman J, Olcen P. Pneumococcal meningitis in adults. Scand J Infect Dis 1994;26:659-66.
36. Sankilampi U, Herva E, Haikala R, Liimatainen O, Renkonen O-V, Leinonen M. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect 1997; 118:7-15.
37. Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect 1996; 117:411-6.
38. Loughlin AM, Marchant CD, Lett SM. The changing epidemiology of invasive bacterial infections in Massachusetts children, 1984 through 1991. Am J Public Health 1995;85:392-4.
39. Guirguis NI, Helmy MF, Mohamed MR, Ali RH. A suggested vaccine formulation for the control of pneumococcal meningitis in Egypt. J Egyptian Public Health Assoc 1990;65:291-303.
40. Muhe L, Klugman K. Pneumococcal and haemophilus meningitis in a children's hospital in Ethiopia: serotypes and susceptibility patterns. Trop Med Int Health 1999;4:421-7.
41. Bogaerts J, Lepage P, Taelman H, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984-1990. J Infect 1993;27:157-68.
42. Colman G, Cooke EM, Cookson BD, Cooper PG, Efstratiou A, George RC, Pneumococci causing invasive disease in Britain 1982-1990. J Med Microbiol 1998;47:17-27.
43. Kornelisse RF, Westerbeek CML, Spoor AB, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 1995;21:1390-7.
44. Brandileone MCDC, Vieira VSD, Zanella RC, et al. Distribution of serotypes of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the Greater Sào Paulo Area, Brazil. J Clin Microbiol 1995;33:2789-91.
45. Brandileone MCDC, Vieira VSD, Casagrande ST, et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Microb Drug Resist 1997;3:141-6.
46. Hortal M, Algorta G, Bianchi I, et al. Capsular type distribution and susceptibility to antibiotics of Streptococcus pneumoniae clinical strains isolated from Uruguayan children with systemic infections. Microb Drug Resist 1997;3:159-63.
47. Levine MM, Lagos R, Levine OS, et al. Epidemiology of invasive pneumococcal infections in infants and young children in metropolitan Santiago, Chile, a newly industrializing country. Pediatr Infect Dis J 1998; 17:287-93.
48. Gratten M, Montgomery J. The bacteriology of acute pneumonia and meningitis in children in Papua New Guinea: assumptions, facts and technical strategies. PNG Med J 1991;34:185-98.
49. Verhaegen J, Glupczynski Y, Verbist L, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis 1995;20:1339-45.
50. Urwin G, Yuan MF, Hall LMC, Brown K, Efstratiou A, Feldman RA. Pneumococcal meningitis in the northeast Thames region. UK: epidemiology and molecular analysis of isolates. Epidemiol Infect 1996; 117: 95-102.
51. Klein JO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981; 3:246-53.
52. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
53. Makela PH, Leinonen M, Pukander J, Karma P. A study of the pneumococcal vaccine in prevention of clinically acute attacks of recurrent otitis media. Rev Infect Dis 1981; 3:S124-30.
54. Karma P, Pukander J, Sipila M, et al. Prevention of otitis media in children by pneumococcal vaccination. Am J Otolaryngol 1985;6:173-84.
55. Hansman D. Serotypes in pneumococcal disease - a ten year study in Australia, 1970 through 1979. Austr NZ J Med 1983; 13:359-64.
56. Douglas RM, Miles H, Hansman D, Moore B, English DT. Microbiology of acute otitis media with particular reference to the feasibility of pneumococcal immunization. Med J Aust 1980; 1:263-6.
57. Mogdasy MC, Camou T, Fajardo C, Hortal M. Colonizing and invasive strains of Streptococcus pneumoniae in Uruguayan children: type distribution and patterns of antibiotic resistance. Pediatr Infect Dis J 1992; 11: 648-52.
58. Hausdorff WP. Prospects for the use of new vaccines in developing countries: cost is not the only impediment. Vaccine 1996; 14:1179-86.
59. Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 1997; 16:1060-4.
60. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KD. Immunogenicity and impact on carriage of nonvalent pneumococcal conjugate vaccine. J Infect Dis 1999; 180:1171-6.
61. Obaro S, Adegbola RA, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination [letter]. Lancet 1996; 348:271-2.